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Carla Oliveira a,b, Roberta Ströher Toledo a,c, Vanessa Leal Scarabelot a, Rafael Vercelino a, 
Lisiane Santos da Silva a,d, Gabriela Gregory Regner a, Andressa de Souza a, 
Natalia Paula Silveira a, Wolnei Caumo d, Iraci L.S. Torres a,c,d,* 
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A B S T R A C T   
In the present study, we investigated the effect of repeated neonatal morphine exposure and/or maternal 
deprivation(MD) on the nociceptive response and central biomarkers’ BDNF, IL-1β, and IL-4 levels at postnatal 
days 16(PND16), 30(PND30), and 60(PND60). At birth, the litters were standardized to contain 8 pups/dam 
(n = 58). From PND1 to PND10, the pups of the deprived groups were separated daily from their mothers for 3 h 
and divided into 5 groups: control(C), saline(S), morphine(M), deprived-saline(DS), and deprived-morphine 
(DM). The pups received subcutaneous injections of saline/morphine (5 μg) in the mid-scapular area between 
PND8 and PND14. Nociceptive responses were assessed by hot plate(HP) and tail-flick(TFL) tests and biomarker 
levels by ELISA. Thermal hyperalgesia(HP) was found in all assessments for the M, DS, and DM groups, and a 
decrease in nociceptive threshold(TFL) was found in the DS group at PND16; M and DM groups at PND30; and M, 
DS, and DM groups at PND60. There were interactions between treatment/deprivation/timepoint in all central 
biomarkers’ levels. The current study indicates that neonatal exposure to morphine and MD, which occurs in the 
pediatric ICU, can alter the nociceptive and neuroinflammatory responses.   
1. Introduction 
Neonatal stress can induce long-term changes in pain sensitivity [1]. 
Some early sensory experiences can induce alterations in neural devel-
opment and behavior until adulthood [2]. Maternal deprivation (MD) is 
an early life stressor which can have lasting effects extending into 
adulthood, as an alteration in the nociceptive response and the analgesic 
efficacy, as nociceptive response and analgesic efficacy [3,4]. 
The nociceptive system in development is especially vulnerable to 
noxious stimuli [5,6]. Newborn infants hospitalized in a neonatal 
intensive care unit may experience significant stressors, including 
repeated painful procedures, as well as MD [7]. Opioid analgesics, such 
as morphine, are the most effective at reducing pain and stress. They 
frequently are used in pediatric care despite the concerns about both 
short- and long-term detrimental effects [8,9]. Our group has shown that 
neonatal morphine exposure promotes long-term changes in nociceptive 
pathways and alters glutamate signaling and the opioid response in 
adult life [10–12]. In addition, repeated low-dose morphine adminis-
tration in neonatal rats induces hyperalgesia in adult life, which could be 
reversed by a glutamate receptor antagonist [12] or by melatonin 
administration [13]. MD during childhood induces long-lasting alter-
ations in the regulation of the endogenous opioid system in humans as 
well as animals [14,15]. Our recent studies showed that MD in early life 
alters neurotrophins and neuroinflammatory cytokines and promotes 
analgesia in adolescent rats and hyperalgesia in adult rats [16,17]. 
It is important to highlight that the processing and modulation of 
nociceptive signals involves the interaction between immunologic mecha-
nisms in the spinal dorsal horn and the transmission of nociceptive infor-
mation to the brain [18,19]. A study by our group showed that early life 
morphine treatment increases hippocampus BDNF levels, a neurotrophin 
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associated with central sensitization in the medium and long-term [20]. 
Similarly, preclinical studies showed that maternal separation stress alters 
BDNF levels in limbic areas [21,22]. However, animal studies suggest that 
morphine may affect immune functions by increasing the secretion of 
proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), 
interleukin-6 (IL-6), and interleukin-1beta (IL-1β) [23,24]. Previous 
research has demonstrated that neuroinflammatory reactions appear to be 
an immunological consequence due to early life parental neglect [25,27]. 
Animals undergoing MD showed an unbalance of the expression of several 
cytokine genes in the rat brain, such as IL-1β and IL-4, suggesting an 
immunosuppressive response [28]. Accordingly, cytokines contribute to 
the deregulation of the hypothalamic–pituitary–adrenal axis and promote 
alterations in neural plasticity, including a decrease in neurotrophic sup-
port and an impaired neurogenesis [29,30]. 
Considering the importance of a deeper understanding of the effects 
of opioid neonatal analgesia and MD throughout life, the aim of this 
study was to investigate whether repeated morphine exposure and/or 
MD alter the nociceptive response over the short, medium, and long 
term. In addition, we evaluated their repercussions upon the levels of the 
central biomarkers BDNF, IL-1β and IL-4. 
2. Material and Methods 
2.1. Animals 
A total of 58 male pups were utilized and were maintained, in the 
presence of their mothers, in home cages made of polypropylene 
(49 × 34 x 16 cm) with the floor covered with sawdust. They were 
maintained under a standard 12-h dark/light cycle (lights on at 7:00a.m. 
and lights off at 7:00p.m.) in a temperature-controlled environment 
(22 ± 2 ◦C) and had access to water and chow ad libitum. At birth, the 
male litters were standardized according to Rozisky et al. [10,11] to 
contain 8 male pups per dam, the same number of breasts of a female rat, 
to certify that every animal would have equal access to the mother’s 
breast during lactation, thereby providing equivalent nutritional con-
ditions for all pups [31]. On postnatal day 21(PND21), the rats were 
weaned. All experiments and procedures were approved by the Institu-
tional Committee for Animal Care and Use (GPPG/HCPA #150614) and 
conducted in compliance with the Laboratory Guide for the Care and Use 
of Animals (The National Academies Press, Eighth Edition, 2011). All 
experiments were conducted under a blind condition and complied with 
the ethical and methodological standards of the ARRIVE guidelines [32]. 
2.2. Experimental Design 
The animals were divided in 5 groups: the total control-group (C), 
without any intervention; the saline-group (S) which received saline 
solution; the morphine-group (M) which received morphine; the 
deprived-saline-group (DS), submitted to MD and received saline solu-
tion; and the deprived-morphine-group (DM), submitted to MD and 
received morphine. The nociceptive responses were assessed in the short 
(PND16), medium (PND30) and long term (PND60). 
2.3. Maternal Deprivation (MD) 
On PND1, litters were deprived of their mothers for 3 hours/day/10 
days [2,16,17]. Deprivation consisted of removing the mother from the 
home cage, and pups were maintained in the original home cage and 
grouped in the nest in the presence of maternal odor. Cages were 
transferred to a different room kept at 30-32 ◦C to compensate for the 
loss of the mother’s body heat. This protocol alters HPA-axis function-
ality and stress reactivity later in life and quite consistently causes 
deficits in cognitive and emotional behavior [33]. Deprivation was 
carried out between 08:00a.m. and 11:00a.m. Non-deprived rats 
remained undisturbed in the home cage with their mothers. The first 
bedding was changed only on PND11 for all groups. 
2.4. Pharmacological Treatment 
Each animal received saline (C, S and DS groups) or morphine 
administration (5 μg, sc, in the mid-scapular area; M and DM groups) 
once daily for 7 days, starting at PND8. At the beginning of the treatment 
(PND8), the animals weighed an average of 15 g, and the morphine’s 
dose administered was 0.33 mg/kg. However, at the end of treatment 
(PND14), the animals weighed on average about 22 g, and thus the dose 
administered was 0.23 mg/kg. This dose was chosen based on previous 
studies by our research group [12–14,5]. Rats at PND8 have similar 
neurological development to human newborns[], with a physiologically 
immature state [34]. This period is characterized by major brain 
development changes and the plasticity of the nociceptive system [35, 
36]. Subcutaneous administration was chosen to avoid the accidental 
penetration of the viscera, as the pups had very fragile and thin skin. All 
treatments were administered at 11:00 a.m. Morphine sulfate (Dimorf® 
10 mg/ml, Cristália Ltda, São Paulo, Brazil) was provided by Hospital de 
Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil. 
2.5. Nociceptive Tests 
2.5.1. Hot Plate (HP) Test 
Twenty-four hours prior to testing, the animals were habituated to 
the apparatus for 5 min to avoid analgesia induced by the novelty [37]. 
The temperature of the plate was maintained at 55 ± 0.1 ◦C, and 
response was recorded in seconds(s) and a cutoff-time of 20 s was used to 
avoid tissue damage. 
2.5.2. Tail-flick latency (TFL) Test 
The animals were exposed to the apparatus to acclimate to the pro-
cedure 24 h prior to the test session [37]. Each animal was placed on the 
apparatus, and its tail was laid across a nichrome wire coil that was then 
heated using an electric current. A cutoff-time of 10 s was used to avoid 
Fig. 1. Hot Plate (HP): Data are presented as mean ± SEM (n = 58). Groups: C, 
control; S, saline; M, morphine; DS, deprived saline; and DM, deprived 
morphine. Different letters indicate the statistical significance (a-d) between 
groups at different times. 
Fig. 2. Tail-Flick (TFL): Data are presented as mean ± SEM (n = 58). Groups: C, 
control; S, saline; M, morphine; DS, deprived saline; and DM, deprived 
morphine. Different letters indicate the statistical significance (a-c) between 
groups at different times. 
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tissue damage [38]. Three TFL baselines were taken at 3 min intervals. 
2.6. Tissue Collection 
2.6.1. Biochemical Assays 
The tissue homogenates were prepared with a handheld homoge-
nizer containing Protease Inhibitor Cocktail (Sigma®#P8340) diluted in 
phosphate buffered saline (PBS, pH 7.2) in a proportion of 1:100. 
Samples were then centrifuged for 5 min at 10.000 rpm, and the su-
pernatant was applied in the BDNF, IL-1β and IL-4 assays, as determined 
by sandwich-ELISA, using monoclonal antibodies specific for each 
measurement (R&D Systems, Minneapolis, United States). Optical den-
sity was measured using an ELISA reader (Hexis - SpectraMax M3) at a 
wavelength of 450 nm. Each tissue homogenate had its total protein 
measured by Bradford’s method, using bovine serum albumin as stan-
dard, and dividing each by its biomarker value. In this way, data were 
expressed in a pg/mg of the protein. 
2.7. Statistical Analysis 
Data were expressed as mean ± standard error of the mean(SEM). 
Differences were considered statistically significant if P < 0.05. SPSS 
20.0 was used for statistical analysis. A Generalized Estimating Equation 
(GEE) followed by Bonferroni was performed to analyze the results of 
nociception. If a statistically significant interaction was found, addi-
tional pairwise comparisons were made. The significance of the effects 
was determined by the Wald chi-square statistic. Biochemical data were 
analyzed by three-way ANOVA followed by the Student Newman–Keuls 
(SNK) test. To verify the ontogenic effect of biomarkers considering the 
analyzed structure, control group data were analyzed by two-way 
ANOVA followed by the SNK test. 
3. Results 
3.1. Nociceptive Tests 
3.1.1. HP Test 
In the HP test, there was an interaction group˟time (Wald χ2 = 32.44; 
8, P < 0.05). Thermal hyperalgesia was indexed by a significant decrease 
in paw withdrawal latency at PND16, PND30, and PND60 for the ani-
mals of the groups M, DS, and DM (Fig. 1). 
3.1.2. TFL Test 
GEE analysis showed an interaction group˟time (Wald χ2 = 36.07; 8, 
P < 0.05). There was a significant decrease in the nociceptive threshold, 
as evidenced by the reduction in the latency time in the DS group at 
PND16, the M and DM groups at PND30, and the M, DS, and DM groups 
at PND60 (Fig. 2). 
3.2. Biochemical Analysis 
3.2.1. Biomarkers Baseline Levels 
First, we compared brainstem and cerebral cortex levels of BDNF, IL- 
1β and IL-4 in the control groups to show that the basal level is different 
for each brain structure. In relation to the BDNF, we observed an effect 
of age and interactions between age˟structure (two-way ANOVA/SNK, 
F(1,38) = 19.20; F(1,38) = 26.28, respectively, P < 0.05) (Fig. 3, Panel A). 
The analysis of IL-1β showed an effect of age and interaction between 
age˟structure (two-way ANOVA/SNK, F(1,38) = 4.42; F(1,38) = 4.45, 
respectively P < 0.05) (Fig. 3, Panel B). In the analysis of IL-4, we 
Fig. 3. Baseline Levels of Biomarkers: Data are presented as mean ± SEM (n = 44). Group: C, control. Brainstem and cerebral cortex BDNF, IL-1β, and IL-4 levels. 
Panel A: BDNF levels. *Significant effect of age. #Interaction between age˟structure. Panel B: IL-1β levels. *Significant effect of age. #Interaction between age 
˟structure. Panel C: IL-4 levels. #Significant effect of structure. 
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observed an effect of the structure (two-way ANOVA/SNK, 
F(1,38) = 7.39, P < 0.05) (Fig. 3, Panel C) on the biomarkers. 
3.2.2. BDNF levels in the brainstem and cerebral cortex 
The brainstem BDNF levels analyses demonstrated interactions be-
tween treatment˟deprivation, deprivation˟time, and treatment˟time-
point (three-way ANOVA/SNK, F(1,102) = 11.98; F(2,102) = 5.24; 
F(4,102) = 4.28, respectively, P < 0.05) (Fig. 4, Panel A). There was an 
effect of treatment in the cerebral cortex levels (three-way ANOVA/SNK, 
F(3,103) = 3.43, P < 0.05) and time (three-way ANOVA/SNK, 
F(2,103) = 111.35, P < 0.05) (Fig. 4, Panel B). 
3.2.3. Brainstem and cerebral cortex IL-1β levels 
In the IL-1β brainstem levels there were interactions between treat-
ment˟deprivation, deprivation˟time, and treatment˟time (three-way 
ANOVA/SNK, F(1,103) = 4.37; F(2,103) = 7.41; F(4,103) = 10.63, respec-
tively, P < 0.05) (Fig. 5, Panel A). In the cortex levels, there was an 
interaction between treatment˟deprivation˟time (three-way ANOVA/ 
SNK, F(2,103) = 3.32, P < 0.05) (Fig. 5, Panel B). 
3.2.4. Brainstem and cerebral cortex IL-4 levels 
We found an interaction between deprivation˟time and treatment 
˟time in brainstem IL-4 levels (three way ANOVA/SNK, F(2,103) = 4.71; 
F(4,103) = 11.51, respectively, P < 0.05) (Fig. 6, Panel A). In the cortex 
levels, there were interactions between treatment˟deprivation˟time 
(three-way ANOVA/SNK, F(2,103) = 4.72, P < 0.05) (Fig. 6, Panel B). 
4. Discussion 
The current study shows that both early morphine exposure and MD 
have significant effects on nociception and central biomarkers 
throughout the life of the rats. Our data showed that morphine exposure 
and/or MD induced thermal hyperalgesia in the short (PND16), medium 
(PND30), and long (PND60) term when evaluated in the HP. Likewise, 
we observed that MD induced hyperalgesia at PND16, and a decrease in 
the nociceptive threshold in the TFL induced by morphine exposure 
and/or MD at PND60. 
In the neonatal period, there is great interaction between the mother 
and the offspring. MD is a stress situation for newborns capable of 
promoting lasting effects on behavioral responses, including noci-
ception, which can extend into adulthood [16]. There are inconsistent 
findings in the literature regarding MD and its effects on behaviors, 
biomarkers, and signaling pathways, possibly due to the different 
deprivation protocols used in pre-clinical studies (see [39] for review). 
MD markedly disrupts opioid system development, decreases the anal-
gesic effects of morphine [43,44], and induces an opioid system hypo-
function [41,42]. In this way, the hyperalgesia induced by MD found in 
our study might be related to changes in central opioid activity pro-
moted by this early life stressor [40,43]. 
From two different methodological nociceptive evaluations, TFL and 
HP tests, we demonstrated that rats in the neonatal period might be 
more sensitive to low doses of morphine, since in the first 3 postnatal 
weeks, there is extensive re-modeling of opioid receptor expression [45]. 
Fig. 4. BDNF Levels: Data are presented as mean ± SEM (n = 58). Groups: C, control; S, saline; M, morphine; DS, deprived saline; and DM, deprived morphine. Panel 
A: Brainstem. *Interaction between treatment˟deprivation, deprivation˟time and treatment˟time. Panel B: Cerebral cortex. *Effect of treatment and #timepoint. 
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In addition, there is evidence that repeated neonatal opioid exposure 
leads to spinal cord neuronal hyperactivity, inducing neuroplasticity 
[46,47] and changes in the supraspinal pain modulatory circuits [48]. 
Opioids can induce hyperalgesia under many circumstances, which 
might contribute to the drawbacks of acute and chronic administration 
of these drugs [48]. Furthermore, chronic exposure to opioids induces 
functional alteration in the spinal cord neurons that can manifest as 
neuronal hyperactivity during opiate withdrawal [49,50]. 
Chronic opioid exposure during infancy may alter the number and 
sensibility of opioid receptors, altering the development of the CNS and 
promoting opioid desensitization throughout life [51,52]. These effects 
may result from a general reorganization in the structure and function of 
primary afferent synapses, neurotransmitter/receptor expression and 
function, and excitatory and inhibitory modulation from higher brain 
centers [34]. Our research group has already demonstrated that 
morphine exposure during early life can alter the developing nervous 
system, promoting long-lasting neurochemical and behavioral alter-
ations in rodents [10,12,53,54]. The outcomes of the present study, 
associated with previous data of our research group, suggest that 
administration of morphine in the first weeks of life, a period of opioid 
system development, may play an important role in the nociceptive 
sensitivity of adult rats inducing a long-lasting alteration on the phar-
macological, neurochemical and behavioral responses. In addition, it 
might lead to drug-induced adaptations in the excitatory pain pathways, 
such as neuroplastic changes at the receptor level, in number and 
activity [11,55]. 
We also observed specific-tissue profiles of neuroimmuno- 
modulators linked to early neonatal pain conditions as an ontogenic 
effect, suggesting an age and site-specific response. The BDNF, IL-1β and 
IL-4 brainstem levels were higher than the cortex levels, independent of 
the age. This result corroborates our previous studies where it was 
possible to observe that BDNF is less expressed in the cerebral cortex 
than other brain structures in young and adult rats [16,56]. In this way, 
we can suggest the normal pattern of the distribution of these bio-
markers in the CNS involves lower expression in the cerebral cortex than 
in other brain structures. The higher centers of the CNS have the ability 
to modulate the nociceptive transmission, and a variety of brain regions 
are involved in this descending modulation and include the frontal lobe, 
anterior cingulate cortex, insula, and amygdala [57]. Opioid receptors 
are found throughout the brain and spinal cord and influence many 
central functions, such as nociception. These receptors are distributed 
differently within the central and peripheral nervous systems, present-
ing functional differences in various structures [61]. In the current 
study, morphine induced long lasting increases in the BDNF brainstem 
levels, corroborating our previous studies that showed a long-lasting 
increase in the central BDNF and NGF levels [20,54]. It is important 
to highlight that NGF seems to be involved in social stress, since studies 
have shown that changes in its levels result in the development of 
adequate strategies to face the stressor itself and, thus, survive [58]. MD 
alters BDNF levels in limbic areas promoting long-lasting changes upon 
Fig. 5. IL-1β Levels: Data are presented as mean ± SEM (n = 58). Groups: C, control; S, saline; M, morphine; DS, deprived saline; and DM, deprived morphine. Panel 
A: Brainstem. *Interaction between treatment˟deprivation, deprivation˟time and treatment˟time. Panel B: Cerebral cortex *Interaction between treatment˟depri-
vation˟time. 
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emotional behavior and responses to stress [21,22]. This indicates that 
neurotrophins modulate mechanisms underlying social bonding, and 
they are sensitive to the handling of the mother-infant relationship and 
to the rearing environment [21]. Corroborating our results, changes in 
BDNF expression have been shown to be age, time, and stimulus specific 
[17,21]. In clinical studies, both positive and negative correlations be-
tween age and BDNF levels have been reported, which may be due to 
environmental modulation of the central and peripheral levels [59,60]. 
We observed that the daily saline injection increased IL-1β brainstem 
levels, which itself can be considered as an early life stress model. 
Morphine and MD increased IL-1β and IL-4 levels in the cortex and 
brainstem, respectively, and these effects are reverted b associated in-
terventions. Early life challenges alter the phenotype of immune cells, 
inducing a sensitized state, which can promote an exacerbated reaction 
later in life, causing greater vulnerability to neurological diseases [61]. 
Our results corroborate preclinical and clinical studies that show that 
exposure to negative early life experiences result in alterations to the 
immune and inflammatory responses, modulating inflammatory pro-
cesses in adult life [27,62]. One limitation of our study was that it was 
conducted only with male rats, since the nociceptive process and drug 
responses can be altered by modulations in the hormone state [63]. 
The current study indicates that neonatal exposure to morphine and 
to MD, as can occur in a pediatric ICU, can alter the nociceptive and 
neuroinflammatory responses, which can be related clinical conditions 
involving chronic pain. This illustrates the need to examine nociceptive 
processing in human neonate patients that have been exposed to 
therapeutic morphine and indicates the importance of research evalu-
ating the clinical consequences of long-term opioid administration. In 
summary, this study emphasizes the importance of conducting research 
that may counteract opioid and/or MD-induced neuroadaptations to 
subsequently prevent abnormal pain states and to provide a compre-
hensive knowledge of their long-lasting effects upon nociceptive and 
neurochemical pathways. 
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